Enliven Therapeutics ELVN Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Enliven Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's operating lease liabilities (total)?
- Enliven Therapeutics (ELVN) reported operating lease liabilities (total) of $302K in Q1 2026.
- How has Enliven Therapeutics's operating lease liabilities (total) changed year-over-year?
- Enliven Therapeutics's operating lease liabilities (total) decreased by 56.9% year-over-year, from $700K to $302K.
- What is the long-term trend for Enliven Therapeutics's operating lease liabilities (total)?
- Over 2 years (2021 to 2025), Enliven Therapeutics's operating lease liabilities (total) has grown at a -21.8% compound annual growth rate (CAGR), from $652K to $399K.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.